The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

Laine, Roger A

Laine, Roger A.

Laine RA; Departments of Biological Sciences and Chemistry, Louisiana State University and A&M College, Baton Rouge, LA 70803, USA.

Glycobiology ; 30(10): 763-767, 2020 09 28.

Article in English | MEDLINE | ID: covidwho-727050

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/pharmacology; Antiviral Agents/pharmacology; COVID-19 Drug Treatment; Inflammation/drug therapy; SARS-CoV-2/drug effects; Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis; Anti-Inflammatory Agents, Non-Steroidal/chemistry; Antiviral Agents/chemical synthesis; Antiviral Agents/chemistry; Glycosylation; Humans; Ligands; Microbial Sensitivity Tests

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Anti-Inflammatory Agents, Non-Steroidal / SARS-CoV-2 / COVID-19 Drug Treatment / Inflammation Limits: Humans Language: English Journal: Glycobiology Journal subject: Biochemistry Year: 2020 Document Type: Article Affiliation country: Glycob

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google